World Muscle Society “25 Challenge” to support Muscular Dystrophy Canada

Many neuromuscular specialists and members of multidisciplinary neuromuscular teams in Canada are part of the World Muscle Society (WMS). WMS provides a multidisciplinary scientific forum to advance and disseminate knowledge in the neuromuscular field for the benefit of patients; stimulates, encourages, and helps to develop programs for professionals working in the neuromuscular field; and promotes the achievement of standards in clinical practice.

This year, the global WMS 2020 meeting was scheduled to take place in beautiful Nova Scotia, Canada and was meant to mark WMS’s 25th anniversary year. But due to COVID-19, the meeting was re-envisioned as a first-ever virtual congress.

Because people living with neuromuscular conditions have been hit particularly hard by the COVID-19 pandemic, WMS has asked all WMS 2020 Congress attendees to get involved by taking on their very own WMS “25 Challenge” to raise money and awareness for relevant charities across the world.

Muscular Dystrophy Canada (MDC), a funder and partner of NMD4C, has been selected as the neuromuscular organization of choice for Canada. This call for support is timely: Due to the COVID-19 pandemic, MDC has seen an increased demand for mental and emotional well-being supports, evidence-based information, essential equipment and advocacy for equity-focused policies. But while there has been an increased demand for their programs and services, the pandemic has significantly affected their available funding. Since the pandemic, MDC has experienced a 60% decrease in revenue. All of their in-person fundraising events have been cancelled and this has been challenging as their organization relies on their supporters and donors to fuel their mission. There has been a 40% cut to funding for the equipment program and a 75% cut to the budget for the Annual Research Grant Competition. In the past year they funded over $1.6 million of research grants and leveraged additional funding for a total of approximately $3.5 million towards team grants and supporting infrastructure. They funded over $1 million in essential equipment and technology supports for people living with neuromuscular disorders, but today they have over 100 individuals on the wait list to receive such life-changing equipment.Let’s not slow down the incredible progress that has been made.

 

Let’s keep the momentum going – if you are attending the WMS 2020 meeting, participate in the WMS “25 Challenge” and help raise money for MDC.

 

Click here to get started.

 

Thank you in advance for your support and for positively impacting the lives of Canadians affected by neuromuscular disorders!

 

WMS-Challenge-Facebook-1200x1200-white-teal (1)

Read next...

NEWS_Scheduled Website Maintenance

Scheduled Maintenance

Please note that this website, imPORTND, and the NNLS training platform will undergo maintenance from July 23 until July 27, 2026.

NMD4C Talent Pool

Discover Neuromuscular Talent Across Canada

The NMD4C Neuromuscular Talent Pool is now live with new trainees! We invite supervisors and research groups to explore the Talent Pool to identify candidates whose skills, experience, and interests align with your work and upcoming positions. Trainees interested in being included in the Neuromuscular Talent Pool can register by completing the short form, uploading a CV and brief personal statement outlining their experience, interests, and career goals. For more information and to access the Talent Pool, please visit our website.

2026 NMD4C Annual Meeting Registration is Open

Join Us at the 2026 NMD4C Annual Meeting on 25 September

The 2026 NMD4C Annual Meeting will take place in Calgary on Friday, September 25, 2026. The agenda will feature a brief network update, trainee and early-career recognitions, flash talks, a health economics research showcase, and a series of cross‑disciplinary and parallel clinical/pre‑clinical discussion sessions to explore key topics, including advocacy and therapy access, strategies to sustain and strengthen pre-clinical programs, and network sustainability and strategic planning.